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Background
Autoantibodies (Abs) to SSA/Ro recognize two ribonu-
cleoproteins of 52- and 60-kDa. Ro52 antigen is an E3-
ubiquitin-ligase. Anti-Ro52 Abs are present in patients
with a broad spectrum of autoimmune diseases.
Usually these Abs are in association with anti-Ro60 in
lupus erythematosus (SLE) and Sjögren syndrome (SS).
However, isolated anti-Ro52 is frequently present in
inflammatory myositis.
Objective
To analyze the prevalence of anti-Ro52 and Ro60 Abs in
a cohort of patients from a third level hospital with sus-
pected diagnosis of autoimmunity.
Materials and methods
Serum samples from 1100 patients, collected at the
Immunology laboratory, HUGTP, from January 1999
until February 2009, that were tested for the presence of
Abs against Extractable Nuclear Antigens (ENAs) using a
commercial immunoblotting (Innolia) and ELISA assays
(Orgentec). Most of the samples had a positive result in
the anti-nuclear antibodies (ANAs) test.
Data were collected and analyzed in a retrospective
way, and classified depending on the reported diagnostic
in the medical history.
Results
99 patients were Ro52+ Ro60- (group 1), 22 Ro52- Ro60+
(group 2), and 18 Ro52+ Ro60+ (group 3). In group 1, 7%
patients had rheumatoid arthritis (RA) or other forms of
autoimmune arthritis; 11% systemic sclerosis (SSc); 6%
autoimmune hepatopathy (AH); 5% myositis; 20% SLE
and 13% SS; Group 2 included 64% SLE, 4.5% SS, 4.5%
psoriasis and 9% vasculitis. Finally, group 3 contained 39%
SS, 28% SLE, 11% SSc, 5.5% AH, 5.5% RA.
Conclusion
The finding of an isolated response to Ro52 is related
mostly to SLE and SS, while an isolated response to Ro60
is present more frequently in SLE. In group 2 we found
neither AR nor AH nor SSc. Markedly, patients diagnosed
with myositis were only present in group 1.
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